Chiron Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1,000K | Sell |
9,015
-1,408
| -14% | -$156K | 0.87% | 37 |
|
|
2025
Q1 | $1.17M | Sell |
10,423
-12,451
| -54% | -$1.4M | 1.06% | 25 |
|
|
2024
Q4 | $2.11M | Sell |
22,874
-6,003
| -21% | -$555K | 1.99% | 6 |
|
|
2024
Q3 | $2.42M | Sell |
28,877
-8,398
| -23% | -$704K | 2.14% | 6 |
|
|
2024
Q2 | $2.56M | Buy |
37,275
+17,704
| +90% | +$1.21M | 2.44% | 3 |
|
|
2024
Q1 | $1.43M | Buy |
19,571
+6,291
| +47% | +$461K | 1.3% | 18 |
|
|
2023
Q4 | $1.08M | Sell |
13,280
-2,898
| -18% | -$235K | 0.94% | 29 |
|
|
2023
Q3 | $1.21M | Sell |
16,178
-1,500
| -8% | -$112K | 1.04% | 24 |
|
|
2023
Q2 | $1.36M | Sell |
17,678
-5,900
| -25% | -$455K | 1.08% | 19 |
|
|
2023
Q1 | $1.96M | Sell |
23,578
-16,712
| -41% | -$1.39M | 1.36% | 9 |
|
|
2022
Q4 | $3.46M | Sell |
40,290
-61,840
| -61% | -$5.31M | 2.41% | 6 |
|
|
2022
Q3 | $6.3M | Sell |
102,130
-1,048
| -1% | -$64.6K | 4.23% | 4 |
|
|
2022
Q2 | $6.38M | Buy |
103,178
+5,451
| +6% | +$337K | 4.02% | 4 |
|
|
2022
Q1 | $5.81M | Buy |
97,727
+10,053
| +11% | +$598K | 3.66% | 4 |
|
|
2021
Q4 | $6.37M | Sell |
87,674
-7,068
| -7% | -$513K | 4.6% | 2 |
|
|
2021
Q3 | $6.62M | Sell |
94,742
-24,464
| -21% | -$1.71M | 4.83% | 2 |
|
|
2021
Q2 | $8.21M | Sell |
119,206
-4,589
| -4% | -$316K | 6.84% | 2 |
|
|
2021
Q1 | $8M | Sell |
123,795
-3,060
| -2% | -$198K | 6.79% | 2 |
|
|
2020
Q4 | $7.39M | Sell |
126,855
-1,863
| -1% | -$109K | 6.09% | 2 |
|
|
2020
Q3 | $8.13M | Buy |
+128,718
| New | +$8.13M | 6.55% | 2 |
|